One year on GLP-1...whoa!

[evidence-based]

got maybe a few pounds of flab nothing major, need to hit the gym soon. even when i'm at goal weight don't plan to quit. might taper to one pin a week instead of two and drop my dose maybe, but without long-term harm data i don't see stopping

 

[Eddie09]

yeah i feel you. 8+ years is a solid stash honestly. pinning a needle once a week to keep food noise down and hunger manageable is low maintenance for life. might get better options like weekly pills down the road but for now this works.

 

[Shannon_04]

you're doing great! really need to jump your dose? are you tracking food? maybe push more cardio instead. i started 2.5mg late '25, hit my goal by march. had stalls but kept walking daily, logging everything. weight eventually shifted. 20 days between doses now, works solid.

 

[Chris02]

magnesium changed the game for me at 2.5mg. went hard on it daily and the nausea, stress, constipation all dropped way down. mood got better too. might be worth trying if you're hitting side effects early.

 

[Gang31]

That first dose shakes your system up — signals things are changing. Initial weight drop's partly that signal plus other changes you make starting out. But that starter dose did its job, time to move to the next box. 0.25 to 0.5, four weeks at a dose, no benefit lagging the schedule.

 

[SnackRN]

so happy to see stories like this. you should be proud. started wegovy last summer at 322, dropped 30 quick but plateaued in january and gained back in march. just switched to mounjaro. really hoping i'll get where you are one day.

 

[TrevorC95]

So going from 260lbs targeting 180-200 at 5'7" works out to a starting BMI around 42 and an ending BMI near 29. Age wasn't clear, guessing 40s based on context.

If it hasn't happened yet, a basic cardiovascular workup is worth getting, blood pressure, blood sugar, hb1ac, lipids, liver and kidney function. Mainly useful because worse numbers make early action more urgent before real damage sets in, and it strengthens the case for staying on this medication class for the foreseeable future. At a BMI around 42, metabolic syndrome and elevated heart risk are probably already in the picture, so cholesterol medication might come up as a conversation too.

Haven't come across solid proof yet that a lower amount or spacing doses out further actually holds up as a real maintenance approach over time. Trial settings with heavy support and monitoring tend to see smaller rebounds than what happens in ordinary life without that structure. And even those reduced-dose trials still show some weight creeping back, just less than stopping altogether would. Genuinely more long-range research is needed here.